Home / Pharmaceutical company intelligence
RASCO PHARMA logo
Pharmaceutical company intelligence

RASCO PHARMA products and prices in Pakistan

Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.

Follow price changes 🔒 Company report (Pharma Pro)

Pharmaceutical manufacturer · Lahore · Pakistan

Lahore pharmaceutical manufacturer operating since 2004 with generic medicines, quality-control infrastructure and multiple dosage forms.

RASCO PHARMA products in Pakistan

RASCO PHARMA has 83 medicine presentations registered in Pakistan under 44 brands, covering 34 generic medicines. Most of its products are in Anti-infectives, CNS & mental health and Pain & musculoskeletal. Its brands with the most registered strengths and packs are Rasco Pharmadol (Paracetamol), Resgyl (Metronidazole), B-Lex (Cephalexin) and Le-Tact (Levetiracetam). 83 products have an official DRAP price on MedInfoBase. See all 44 brands A to Z

Database-driven profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public source rechecked
Latest regulatory-source observation11 Nov 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date17 Aug 2026Newest effective date among published current price records
Corporate profile evidence5 sourcesCorporate source details checked 15 Oct 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public source rechecked
Company type
Pharmaceutical manufacturer
Address
5.5 KM, Near Ali Raza Abad, Holiday Park, Plot No. 27, Raiwind Road, Lahore, Pakistan
Phone
+92 42 35230774-5
Official contact
Contact page ↗
Corporate source details checked
15 Oct 2026
Corporate profile completeness
100%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000530 Rasco Pharma (Pvt) Ltd. · Punjab
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000530 83 linked products · source seen 11 Nov 2026 View source ↗
Corporate profile source ledger Profile Source Url source ↗ Logo Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx90public portfolio records represented
REG74unique registrations represented
IDX83indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+7registry-only registrations
VER53registry-verified exact registrations
PKR83current validated price records
G34generic molecules in indexed catalogue
DF7dosage-form groups
TA8therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage92%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage87%
priced packs safely normalized per unit
Comparable-market coverage87%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixRASCO PHARMAShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/rasco-pharmaGenerated 11 Nov 2026Anti-infectives45 · 54%CNS & mental health15 · 18%Pain & musculoskeletal11 · 13%Gastrointestinal & hepatology5 · 6%Cardiovascular2 · 2%Respiratory & allergy2 · 2%Hematology & thrombosis2 · 2%Other therapeutic areas1 · 1%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioRASCO PHARMADistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/rasco-pharmaGenerated 11 Nov 202683presentationsTablet47 · 57%Injection11 · 13%Capsule10 · 12%Suspension10 · 12%Infusion3 · 4%Solution1 · 1%Other forms1 · 1%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionRASCO PHARMACurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/rasco-pharmaGenerated 11 Nov 202672comparable productsBelow peer median13 · 18%Near peer median32 · 44%Above peer median27 · 38%Company median price position+2.7%Lowest-price equivalents1Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsRASCO PHARMACompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/rasco-pharmaGenerated 11 Nov 2026Mediate Pharmaceutical Pvt Ltd28 shared82% overlapNeutro Pharma (Pvt.) Ltd.,26 shared76% overlapZafa Pharmaceutical Laboratories (P…25 shared74% overlapAmarant Pharmaceuticals Private Lim…25 shared74% overlapPulse Pharmaceuticals (Pvt.) Ltd.25 shared74% overlapBio-Labs(Pvt) Ltd24 shared71% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Formulation footprint

Dosage forms

Tablet47 products
Injection11 products
Capsule10 products
Suspension10 products
Infusion3 products
Solution1 products
Syrup1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
🔒
MedInfoBase Pharma Pro

See where RASCO PHARMA is priced against the market

72 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.

Below / near / above medianCompany price positionProduct examplesExcel, PDF & PowerPoint
Unlock with Pharma Pro
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock

Regulatory & price activity

Observed database signals

Indexed registration numbers67Distinct registrations among indexed, published, presentation-validated products only
Verified price observations159
Products with a verified price83
Products with multiple price observations76
Source records with multiple versions82
Latest portfolio source check22 Sep 2026
Latest effective price date17 Aug 2026
Latest source observation11 Nov 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

74 unique registration(s) · 83 indexed presentation(s) · 7 registry-only registration(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
A.Z Ko Azithromycin 250 mg Tablet 10's 040180 PKR 525.25 PKR 52.53/tablet 🔒 Pharma Pro
A.Z Ko Azithromycin 500 mg Tablet 6's 107068 PKR 412.69 PKR 68.78/tablet 🔒 Pharma Pro
Aquaras Water for Injection 5 mL Injection 5mlx100's 085498 PKR 1,101.08 PKR 2.20/mL 🔒 Pharma Pro
AZ-Ko Azithromycin 200 mg/5 mL Suspension 15ml 041630 PKR 329.13 PKR 21.94/mL 🔒 Pharma Pro
AZ-Ko Azithromycin 250 mg Capsule 1x6's 050202 PKR 247.84 PKR 41.31/capsule 🔒 Pharma Pro
AZ-Ko Azithromycin 250 mg Capsule 10's 050202 PKR 508.66 PKR 50.87/capsule 🔒 Pharma Pro
B-Lex Cephalexin 125 mg/5 mL Suspension 60ml 038951 PKR 131.37 PKR 2.19/mL 🔒 Pharma Pro
B-Lex Cephalexin 250 mg/5 mL Suspension 60ml 038952 PKR 227.11 PKR 3.79/mL 🔒 Pharma Pro
B-Lex Cephalexin 500 mg Capsule 12's 038961 PKR 325.45 PKR 27.12/capsule 🔒 Pharma Pro
B-Lex Cephalexin 250 mg Capsule 12's 050655 PKR 164.79 PKR 13.73/capsule 🔒 Pharma Pro
Bactiphin Ceftriaxone 250 mg Injection 1Vial 050657 PKR 201.47 PKR 201.47/vial/unit 🔒 Pharma Pro
Bactiphin Ceftriaxone 500 mg Injection 1Vial 050658 PKR 350.17 PKR 350.17/vial/unit 🔒 Pharma Pro
Bactiphin Ceftriaxone 1 g Injection 1Vial 050659 PKR 640.29 PKR 640.29/vial/unit 🔒 Pharma Pro
Bactiphin 2gm Injection IVRegistry verified Ceftriaxone (as sodium) — — — 138379Official source ↗ No indexed price — —
Benazole Risperidone 1 mg Tablet 2x10's 057203 PKR 239.36 PKR 11.97/tablet 🔒 Pharma Pro
Benazole 2Tablet Risperidone 2 mg Tablet 2x10's 057204 PKR 388.96 PKR 19.45/tablet 🔒 Pharma Pro
Benazole 3 Risperidone 3 mg Tablet 1x10's 059693 PKR 458.79 PKR 45.88/tablet 🔒 Pharma Pro
Cip-Rx Ciprofloxacin 250 mg Tablet 1x10's 040156 PKR 259.32 PKR 25.93/tablet 🔒 Pharma Pro
Cip-Rx Ciprofloxacin 500 mg Tablet 1x10's 040157 PKR 535.55 PKR 53.56/tablet 🔒 Pharma Pro
Cip-Rx Ciprofloxacin 200 mg IV infusion 100ml x1's 078929 PKR 199.47 PKR 1.99/mL 🔒 Pharma Pro
Diazepam Diazepam 5 mg Tablet 3X10's 065714 PKR 40.22 PKR 1.34/tablet 🔒 Pharma Pro
Diazepam Diazepam 2 mg Tablet 3X10's 065721 PKR 24.96 PKR 0.83/tablet 🔒 Pharma Pro
Diazepam-5 Diazepam 5 mg Tablet 1000's Jar 065714 PKR 1,300.30 — No comparator
Fexatin Fluoxetine 20 mg Tablet 1x10's 040184 PKR 129.66 PKR 12.97/tablet 🔒 Pharma Pro
Goronil Losartan 50 mg Tablet 2x10's 046777 PKR 398.94 PKR 19.95/tablet 🔒 Pharma Pro
Ixalt Artemether + Lumefantrine 20 mg + 120 mg Tablet 16's 063157 PKR 638.30 PKR 39.89/tablet 🔒 Pharma Pro
Ixalt Artemether 80 mg Injection 6's 080018 PKR 1,196.82 PKR 199.47/vial/unit 🔒 Pharma Pro
Kabrokin Carbamazepine 200 mg Tablet 30's 116636 PKR 324.50 PKR 10.82/tablet 🔒 Pharma Pro
Keukin Quetiapine 200 mg Tablet 10's 087503 PKR 1,057.11 PKR 105.71/tablet 🔒 Pharma Pro
Le-Tact Levetiracetam 500 mg Tablet 3X10's 067957 PKR 3,474.35 PKR 115.81/tablet 🔒 Pharma Pro
Le-Tact Levetiracetam 250 mg Tablet 3X10's 067958 PKR 2,095.41 PKR 69.85/tablet 🔒 Pharma Pro
Le-Tact Levetiracetam 500 mg/5 mL Oral solution 60ml 074417 PKR 845.69 PKR 14.09/mL 🔒 Pharma Pro
Le-Tact Levetiracetam 500 mg/5 mL Injection 5mlx1.s 098251 PKR 595.35 — No comparator
Levofloxa-250 Levofloxacin 250 mg Tablet 1x10's 040170 PKR 498.68 PKR 49.87/tablet 🔒 Pharma Pro
Levofloxa-500 Levofloxacin 500 mg Tablet 10's 041626 PKR 829.80 PKR 82.98/tablet 🔒 Pharma Pro
Lortec Loratadine 10 mg Tablet 10'S 032424 PKR 83.78 PKR 8.38/tablet 🔒 Pharma Pro
Lortec Loratadine 5 mg/5 mL Syrup 60ml 032425 PKR 95.74 PKR 1.60/mL 🔒 Pharma Pro
Moxiline Moxifloxacin 400 mg Tablet 1X5's 059698 PKR 978.41 PKR 195.68/tablet 🔒 Pharma Pro
Nilclot Clopidogrel 75 mg Tablet 1X10's 038970 PKR 279.26 PKR 27.93/tablet 🔒 Pharma Pro
Panpak 40mg IV InjectionRegistry verified Pantoprazole sodium eq to Pantoprazole — — — 082763Official source ↗ No indexed price — —
Pharmatran Sulfamethoxazole + Trimethoprim 200 mg + 40 mg / 5 mL Suspension 50ml 032406 PKR 46.76 PKR 0.94/mL 🔒 Pharma Pro
Pharmatran DS Sulfamethoxazole + Trimethoprim 800 mg + 160 mg Tablet 100's Jar 032417 PKR 493.95 — No comparator
Pharmatran DS Sulfamethoxazole + Trimethoprim 800 mg + 160 mg Tablet 10 x 10's 032417 PKR 969.34 PKR 9.69/tablet 🔒 Pharma Pro
Pharmatran Paediatric Sulfamethoxazole + Trimethoprim 40 mg/5 mL + 200 mg/5 mL Suspension 400ml 032406 PKR 153.75 PKR 0.38/mL 🔒 Pharma Pro
Prisma Omeprazole 20 mg Capsule 10x10's 043352 PKR 2,037.17 PKR 20.37/capsule 🔒 Pharma Pro
Prisma Omeprazole 20 mg Enteric-coated tablet 10's 043352 PKR 212.17 PKR 21.22/tablet 🔒 Pharma Pro
Prisma Omeprazole 40 mg Capsule 2x7's 069394 PKR 514.96 PKR 36.78/capsule 🔒 Pharma Pro
Prisma Omeprazole 40 mg IV injection 1 vial 082762 PKR 598.41 PKR 598.41/vial/unit 🔒 Pharma Pro
Prisma-20 Omeprazole 20 mg Capsule 2x7's 043352 PKR 296.61 PKR 21.19/capsule 🔒 Pharma Pro
Quantum Quetiapine 100 mg Tablet 1X10's 067964 PKR 845.69 PKR 84.57/tablet 🔒 Pharma Pro
A to Z

All 44 RASCO PHARMA brands in Pakistan

  • A.Z Ko Azithromycin · 250 mg tablet, 500 mg tablet
  • Aquaras Water for Injection · 5 mL injection
  • AZ-Ko Azithromycin · 200 mg/5 mL suspension, 250 mg capsule
  • B-Lex Cephalexin · 125 mg/5 mL suspension, 250 mg capsule, 250 mg/5 mL suspension
  • Bactiphin Ceftriaxone · 1 g injection, 250 mg injection, 500 mg injection
  • Benazole Risperidone · 1 mg tablet
  • Benazole 2Tablet Risperidone · 2 mg tablet
  • Benazole 3 Risperidone · 3 mg tablet
  • Cip-Rx Ciprofloxacin · 200 mg infusion, 250 mg tablet, 500 mg tablet
  • Diazepam Diazepam · 2 mg tablet, 5 mg tablet
  • Diazepam-5 Diazepam · 5 mg tablet
  • Fexatin Fluoxetine · 20 mg tablet
  • Goronil Losartan · 50 mg tablet
  • Ixalt Artemether + Lumefantrine, Artemether · 20 mg + 120 mg tablet, 80 mg injection
  • Kabrokin Carbamazepine · 200 mg tablet
  • Keukin Quetiapine · 200 mg tablet
  • Le-Tact Levetiracetam · 250 mg tablet, 500 mg tablet, 500 mg/5 mL injection
  • Levofloxa-250 Levofloxacin · 250 mg tablet
  • Levofloxa-500 Levofloxacin · 500 mg tablet
  • Lortec Loratadine · 10 mg tablet, 5 mg/5 mL syrup
  • Moxiline Moxifloxacin · 400 mg tablet
  • Nilclot Clopidogrel · 75 mg tablet
  • Pharmatran Sulfamethoxazole + Trimethoprim · 200 mg + 40 mg / 5 mL suspension
  • Pharmatran DS Sulfamethoxazole + Trimethoprim · 800 mg + 160 mg tablet
  • Pharmatran Paediatric Sulfamethoxazole + Trimethoprim · 40 mg/5 mL + 200 mg/5 mL suspension
  • Prisma Omeprazole · 20 mg capsule, 20 mg tablet, 40 mg capsule
  • Prisma-20 Omeprazole · 20 mg capsule
  • Quantum Quetiapine · 100 mg tablet
  • Ras-Q Hydroxychloroquine · 200 mg tablet
  • Rasco Pharmadol Paracetamol · 120 mg/5 mL suspension, 250 MG/5 mL suspension, 500 mg tablet
  • Rasco Pharmafin Cefotaxime · 1 g injection, 250 mg injection, 500 mg injection
  • Rasco Pharmatran Sulfamethoxazole + Trimethoprim · 400 mg + 80 mg tablet
  • Rasdipin Amlodipine · 5 mg tablet
  • Refspan Cefixime · 100 mg/5 mL suspension, 400 mg capsule
  • Resfen Ibuprofen · 200 mg tablet, 400 mg tablet
  • Resgyl Metronidazole · 200 mg tablet, 400 mg tablet, 500 mg/100 mL infusion
  • Restivan-2 Lorazepam · 2 mg tablet
  • Teransic Tranexamic acid · 500 mg/5 mL injection
  • Theracid-250 Clarithromycin · 250 mg tablet
  • Theracid-500 Clarithromycin · 500 mg tablet
  • Voxicin Doxycycline · 100 mg capsule
  • Vulamox Amoxicillin + clavulanic acid · 500 mg + 125 mg tablet, 875 mg + 125 mg tablet
  • Zolinf Linezolid · 200 mg/100 mL infusion
  • Zyuric Allopurinol · 300 mg tablet
Questions

RASCO PHARMA: common questions

How many products does RASCO PHARMA have in Pakistan?

RASCO PHARMA has 83 registered medicine presentations in Pakistan, sold under 44 brands and covering 34 generic medicines.

What are the main brands of RASCO PHARMA?

By number of registered strengths and packs, its largest brands are Rasco Pharmadol (Paracetamol), Resgyl (Metronidazole), B-Lex (Cephalexin), Le-Tact (Levetiracetam) and Prisma (Omeprazole). This is not a sales ranking.

Which therapy areas does RASCO PHARMA cover?

The most products are in Anti-infectives (45), CNS & mental health (15), Pain & musculoskeletal (11), Gastrointestinal & hepatology (5) and Cardiovascular (2).

Where can I see RASCO PHARMA medicine prices?

Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.

MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). RASCO PHARMA — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved November 11, 2026, from https://medinfobase.com/company/rasco-pharma/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.

Medicine brands A–Z:ABCDEFGHIJKLMNOPQRSTUVWXYZ0-9